| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-12-08 | Growth Equity Opportunities Fund IV, LLC | Addex Therapeutics Ltd. | 7,704,600 | 6.4% | EDGAR |
| SC 13D/A | 2023-11-29 | Dyer Timothy Mark | Addex Therapeutics Ltd. | 16,863,355 | 14.2% | EDGAR |
| SC 13D/A | 2023-04-10 | Growth Equity Opportunities Fund IV, LLC | Addex Therapeutics Ltd. | 7,704,600 | 8.5% | EDGAR |
| SC 13D/A | 2023-04-05 | Dyer Timothy Mark | Addex Therapeutics Ltd. | 9,855,322 | 11.1% | EDGAR |
| SC 13D/A | 2023-03-31 | Dyer Timothy Mark | Addex Therapeutics Ltd. | 9,855,322 | 12.2% | EDGAR |
| SC 13G/A | 2023-02-16 | ARMISTICE CAPITAL, LLC | Addex Therapeutics Ltd. | 675,295 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-14 | CAXTON CORP | Addex Therapeutics Ltd. | 718,849 | 0.9% | EDGAR |
| SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | Addex Therapeutics Ltd. | 4,038,462 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-08 | GOLDMAN SACHS GROUP INC | Addex Therapeutics Ltd. | 2,063 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-06 | New Leaf Biopharma Opportunities I, L.P. | Addex Therapeutics Ltd. | 2,316,293 | 3.0% | EDGAR |
| SC 13D/A | 2022-11-28 | Growth Equity Opportunities Fund IV, LLC | Addex Therapeutics Ltd. | 7,704,600 | 9.7% | EDGAR |
| SC 13D/A | 2022-11-23 | Dyer Timothy Mark | Addex Therapeutics Ltd. | 9,855,322 | 13.5% | EDGAR |
| SC 13D/A | 2022-11-09 | Dyer Timothy Mark | Addex Therapeutics Ltd. | 9,855,322 | 20.0% | EDGAR |
| SC 13D/A | 2022-08-23 | Growth Equity Opportunities Fund IV, LLC | Addex Therapeutics Ltd. | 7,704,600 | 15.1% | EDGAR |
| SC 13D/A | 2022-08-05 | Dyer Timothy Mark | Addex Therapeutics Ltd. | 4,460,500 | 8.4% | EDGAR |
| SC 13G/A | 2022-02-18 | New Leaf Biopharma Opportunities I, L.P. | Addex Therapeutics Ltd. | 2,366,293 | 6.2% | EDGAR |
| SC 13G | 2022-02-15 | ARMISTICE CAPITAL, LLC | Addex Therapeutics Ltd. | 632,797 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-14 | CAXTON CORP | Addex Therapeutics Ltd. | 2,314,489 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-14 | CREDIT SUISSE AG/ | Addex Therapeutics Ltd. | 1,876,604 | 5.0% | EDGAR |
| SC 13G | 2022-02-14 | GOLDMAN SACHS GROUP INC | Addex Therapeutics Ltd. | 3,006,982 | 6.1% | EDGAR |